Randomized, Multicenter, Double-blind, Double-dummy, Parallel-Group Study With an Open-label Extension Phase to Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Phase of Trial: Phase III
Latest Information Update: 23 May 2016
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Sponsors Eisai Inc
- 16 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Feb 2014 According to ClinicalTrials.gov record, Planned End Date changed from 1 Nov 2014 to 1 Jun 2015.